Eli Lilly is the largest equity holder in TRex, which is developing drugs that treat immunological conditions by activating “Treg” cells.
Barchart on MSN
How to play TRXB stock after the TRex Bio IPO
TRex Bio (TRXB) is a biotech newcomer with some heavyweight backing, including pharmaceutical giant Eli Lilly (LLY). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results